Loading grant details…
Completed
NON SBIR/STTR CONTRACTS
NIH (US)
DEVELOPMENT & MANUFACTURE OF ORAL & TOPICAL DOSAGE FORMS - NOVOBIOCIN CAPSULE PRODUCTION BASE (TASK 1) 12 MONTHS & OPTION 1 (TASK 2) A CGMP BATCH SHEL
$4.13M
USD
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | Irisys, Inc. |
| Country | United States |
| Start Date | Apr 19, 2021 |
| End Date | Jul 31, 2024 |
| Duration | 1,199 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10491488 |
Grant Description
The aim of the contract to manufacture Drug Product (Novobiocin is Capsule and Triapine is Injectable)
All Grantees
Irisys, Inc.
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2021
End Year
2024
Grantees
1
Related Grants
PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORO...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$2.78M USD
Frederick National Laboratory for Cancer Research (FNLCR) Ce...
NATIONAL CANCER INSTITUTE
$856.7K USD
Completion of ACTIV-2 Study
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$825.3K USD
Advertisement
